Particularly, inhibition of both Notch1 and Notch2 is responsible of GI toxicities observed in both animal models and patients, while Notch2 is required by CD8+ T cells for their anti-tumor cytotoxicity [18, 19]. Here, CD8A is linked to neoplasm.